Section

Ozempic, Wegovy, other anti-obesity drugs to flood biopharma industry in next 12 months; here’s what’s happening

By Business Today - 4 months ago
Recent advancements in anti-obesity drugs have transformed the market, making them the most impactful trend for the next 12 months. Several anti-obesity drugs expected to come to the market in the next few years, including Ozempic (semaglutide), Mounjaro, Wegovy, and GL0034 (uretoglutide).

Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.